US Federal Court Reopens PMI Patent Lawsuit and Revokes Attorney Fee

Business by Vapor Voice; Mandy Wong
Apr.19.2023
On April 17, the US Court of Appeals for the Federal Circuit (CAFC) overturned the district court's dismissal of a patent lawsuit filed by Healthier Choices Management (HCM) against Philip Morris (PMI).

 

 

On April 17, the US Court of Appeals for the Federal Circuit (CAFC) overturned a district court ruling: the District Court dismissed the patent lawsuit filed by Healthier Choices Management (HCM) against Philip Morris (PMI).

 

HCM Sues PMI for Infringement

 

Tobacco giant Philip Morris (PMI) is facing a patent infringement lawsuit from Florida-based e-cigarette company Healthier Choices Management (HCM). It is reported that HCM accused PMI of infringing its e-cigarette pipe patent, namely US Patent No. 10,561,170. After the prosecution, the district court ruled that PMI did not violate the patent and rejected HCM's application for amendment. Meanwhile, PMI received attorney's fees.

 

The main dispute between the two companies is whether one of PMI's products can trigger a combustion reaction. HCM claims that PMI's product does trigger a combustion reaction, while PMI claims the product is non-combustible. If the product involved combustion, PMI would be found to be infringing HCM's patent.

 

However, the District Court agreed with PMI, holding that the additional exhibits provided by HCM proved that PMI's products did not use combustion technology and therefore found no infringement, and the case was dismissed.

 

HCM Appeals to CAFC

 

HCM appealed against the judgment to the Court of Appeals for the Federal Circuit (CAFC). The CAFC upheld HCM's appeal, arguing that the district court had wrongly dismissed the plaintiff's complaint and denied its application for amendment. Accordingly, CAFC revoked PMI's award of attorney's fees and directed the case to be reopened.

 

HCM also requested that other judges hear the case, but CAFC rejected this request. The case will go back to Judge Timothy C. Batten of the US District Court for the Northern District of Georgia for a second instance.

 

Reference:

U.S. Appeals Court Revives Phillip Morris Patent Suit

 

Also read:

Argentina's Heat-not-burn Ban Causes PMI to Suspend Hundreds of Millions of dollars of Investment in IQOS

*The content of this article is written after the extraction, compilation and integration of multiple information for exchange and learning purposes. The copyright of the summary information still belongs to the original article and its author. If any infringement is found, please contact us to delete it. 

U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion
U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion
An opinion article published by Stars and Stripes argued that the Pentagon’s January nicotine clinical guidelines overemphasize abstinence, fail to reflect the reality that about 30% of active-duty personnel use nicotine, and do not address nicotine pouches as potential harm-reduction products.
Industry Insight
Jun.08
BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%
BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%
According to Investing.com citing Bank of America scanner data for the four weeks ending May 30, U.S. nicotine category performance was mixed, with cigarette, vapor and cigar sales declining while oral tobacco sales rose 5.8%.
Jun.10
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
As cigarette volumes continue to decline, U.S. convenience-store operators are reconfiguring backbar space to accommodate modern oral nicotine products such as nicotine pouches. Industry data show nicotine pouches have become one of the fastest-growing nicotine categories while generating higher margins for retailers.
Jun.12
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13